Harnessing nanomedicine for mucosal theranostics -A silver bullet at last?

Eran Elinav, Dan Peer

Research output: Contribution to journalReview articlepeer-review

Abstract

Inflammatory bowel disease (IBD) has been extensively studied in the last four decades both in animal models and humans. The treatment options remain disappointing, nonspecific, and associated with multiple systemic adverse effects. In this Perspective, we highlight issues related to emerging nanotechnologies designed particularly for treatment and disease management of IBD and discuss potential therapeutic target options with novel molecular imaging modalities.

Original languageEnglish
Pages (from-to)2883-2890
Number of pages8
JournalACS Nano
Volume7
Issue number4
DOIs
StatePublished - 23 Apr 2013

Fingerprint

Dive into the research topics of 'Harnessing nanomedicine for mucosal theranostics -A silver bullet at last?'. Together they form a unique fingerprint.

Cite this